The global medical specialty bags market size reached USD 12.1 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 17.3 Billion by 2033, exhibiting a growth rate (CAGR) of 3.91% during 2025-2033.
Report Attribute
|
Key Statistics
|
---|---|
Base Year
|
2024
|
Forecast Years
|
2025-2033
|
Historical Years
|
2019-2024
|
Market Size in 2024
|
USD 12.1 Billion |
Market Forecast in 2033
|
USD 17.3 Billion |
Market Growth Rate 2025-2033 | 3.91% |
Medical specialty bags refer to portable, high-quality, specially designed bags manufactured from advanced materials, including polyester and polymer films. They aid in maintaining various biological samples in sterilized conditions to avoid leakage and control the spread of diseases caused due to bowel incontinence. On account of these properties, medical specialty bags are extensively used for sterile packaging, eternal feeding, bile gathering and blood and urine sample collection. At present, these bags are commercially available in varying product types, such as continuous ambulatory peritoneal dialysis (CAPD), ice and resuscitation bags.
The increasing health consciousness due to the rising prevalence of various chronic diseases, mostly amongst the rising geriatric population, represents one of the prime factors currently driving the medical specialty bags market growth. This is further supported by the increasing need for customer-focused products and services, which, in turn, is facilitating the widespread product adoption across the globe. In line with this, numerous favorable initiatives undertaken by the government bodies of several countries for strengthening the healthcare infrastructure and enhancing the medical standards through the employment of improved reimbursement packages is acting as another growth-inducing factor. Moreover, the escalating demand for polyvinyl chloride (PVC) bags in the healthcare sector on account of their versatility, affordability, and recyclability qualities, is contributing to the market growth. The extensive utilization of intravenous (IV) therapy bags in several applications, such as surgeries, providing nutrition to the patients, sustaining basal hydration levels and maintaining the correct electrolyte balance is further propelling the market growth. Other factors, such as strategic collaborations between key players and continuous investments in the research and development (R&D) activities in the field of medical science for introducing advanced medical tools and accessories, are creating a positive outlook for the market.
IMARC Group provides an analysis of the key trends in each sub-segment of the global medical specialty bags market report, along with forecasts at the global, regional and country level from 2025-2033. Our report has categorized the market based on product and end user.
Breakup by Product:
Breakup by End User:
Breakup by Region:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Ambu A/S, B. Braun Melsungen AG, Baxter International Inc., Becton Dickinson and Company, Coloplast A/S, ConvaTec Group PLC, Hollister Incorporated, Macopharma, Medline Industries LP, Nolato AB, Pall Corporation (Danaher Corporation), SB-Kawasumi Laboratories Inc. (Sumitomo Bakelite Co. Ltd.) and Terumo Corporation.
Report Features | Details |
---|---|
Base Year of the Analysis | 2024 |
Historical Period | 2019-2024 |
Forecast Period | 2025-2033 |
Units | Billion USD |
Segment Coverage | Product, End User, Region |
Region Covered | Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
Countries Covered | United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
Companies Covered | Ambu A/S, B. Braun Melsungen AG, Baxter International Inc., Becton Dickinson and Company, Coloplast A/S, ConvaTec Group PLC, Hollister Incorporated, Macopharma, Medline Industries LP, Nolato AB, Pall Corporation (Danaher Corporation), SB-Kawasumi Laboratories Inc. (Sumitomo Bakelite Co. Ltd.), Terumo Corporation, etc. |
Customization Scope | 10% Free Customization |
Post-Sale Analyst Support | 10-12 Weeks |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
The global medical specialty bags market was valued at USD 12.1 Billion in 2024.
We expect the global medical specialty bags market to exhibit a CAGR of 3.91% during 2025-2033.
The rising adoption of medical specialty bags for sterile packaging, eternal feeding, bile gathering, etc., as they aid in maintaining various biological samples in sterilized conditions to avoid leakage and control the spread of diseases, is primarily driving the global medical specialty bags market.
The sudden outbreak of the COVID-19 pandemic had led to the postponement of various elective surgical procedures to reduce the risk of the coronavirus infection upon hospital visits and interaction with healthcare professionals, thereby negatively impacting the global market for medical specialty bags.
Based on the product, the global medical specialty bags market has been segregated into anesthesia breathing bags, blood bags, sterile packaging bags, ostomy collection bags, enteral feeding bags, cadaver bags, Continuous Ambulatory Peritoneal Dialysis (CAPD) bags, intravenous fluid bags, and others. Among these, ostomy collection bags currently hold the largest market share.
Based on the end user, the global medical specialty bags market can be bifurcated into hospitals, ambulatory surgical centers, home healthcare, and others. Currently, hospitals exhibit a clear dominance in the market.
On a regional level, the market has been classified into North America, Asia-Pacific, Europe, Latin America, and Middle East and Africa, where North America currently dominates the global market.
Some of the major players in the global medical specialty bags market include Ambu A/S, B. Braun Melsungen AG, Baxter International Inc., Becton Dickinson and Company, Coloplast A/S, ConvaTec Group PLC, Hollister Incorporated, Macopharma, Medline Industries LP, Nolato AB, Pall Corporation (Danaher Corporation), SB-Kawasumi Laboratories Inc. (Sumitomo Bakelite Co. Ltd.), and Terumo Corporation.